Company Filing History:
Years Active: 2022-2024
Title: Emmanuelle Georgi: Innovator in Gastro-Resistant Controlled Release Dosage Forms
Introduction
Emmanuelle Georgi is a distinguished inventor based in Colmar, France. She has significantly contributed to the field of pharmaceuticals, particularly focusing on gastro-resistant controlled release oral dosage forms. With two patents to her name, her innovative work is transforming treatments for specific disorders, showcasing her commitment to enhancing patient care.
Latest Patents
Emmanuelle Georgi's latest patents revolve around the development of gastro-resistant controlled release dosage forms. These disclosures involve a particular compound and its pharmaceutically acceptable salts and solvates. Her formulations aim to improve pharmacokinetic properties, thereby reducing the risk of QT prolongation in patients. This advancement is particularly beneficial for individuals diagnosed with schizophrenia, as it addresses the negative symptoms associated with the condition in patients with the CYP2D6 EM genotype.
Career Highlights
Emmanuelle is currently associated with Minerva Neurosciences, Inc., where she plays a pivotal role in innovation and research. Her expertise in developing advanced pharmaceutical formulations underscores her passion for addressing complex medical challenges. Her contributions not only advance scientific understanding but also enhance therapeutic options available to patients.
Collaborations
Throughout her career, Emmanuelle has worked alongside notable colleagues such as Jay Saoud and Remy Henri Luthringer. These collaborations reflect her ability to thrive in a team environment and foster innovation through shared expertise and ideas. Together, they continue to pave the way for breakthroughs in neuroscience and pharmacology.
Conclusion
Emmanuelle Georgi stands out as a remarkable inventor dedicated to improving patient outcomes through her innovative work in gastro-resistant controlled release dosage forms. Her two patents signify her commitment to advancing pharmaceutical science, ensuring that patients receive the best possible care. As she continues her journey in research and development, Emmanuelle remains an influential figure in the realm of pharmaceuticals.